-
公开(公告)号：US20220233577A1
公开(公告)日：2022-07-28
申请号：US16761107
申请日：2018-11-03
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Molly Krisann Gibson , Nathan Wilson Stebbins , Ruth Thieroff-Ekerdt , Geoffrey A. von Maltzahn
IPC: A61K31/716 , A61K47/10 , A61K35/741 , A61P3/12
Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for treating diseases associated with hyperammonemia, e.g., urea cycle disorders (UCD) and hepatic encephalopathy (HE), e.g., minimal HE (MHE) and overt HE (OHE), and modulating enzyme activities and levels of microbes and taxa, and metabolites (e.g., ammonia) in the microbiome of a subject.
-
公开(公告)号：US20210137964A1
公开(公告)日：2021-05-13
申请号：US16316755
申请日：2017-07-13
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jacob Rosenblum Rubens
IPC: A61K31/715 , A61K35/741 , A61P39/00 , A61P35/00 , A61P3/10 , A61P1/00 , A23L33/125 , A23L33/00 , A23L33/135
Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for modulating exogenous substances, enzyme activities, and drug activities.
-
公开(公告)号：US10702542B2
公开(公告)日：2020-07-07
申请号：US16395929
申请日：2019-04-26
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K45/06 , A61K31/716 , A61K31/733 , A61P1/00 , A61K31/09 , A61K31/11 , A61K31/12 , A61K31/165 , A61K31/34 , A61K31/353 , A61K31/365 , A61K31/366 , A61K31/7034 , A61K31/7048 , A61K31/706 , A61K31/715 , A23L33/10 , A23P10/00 , A61K31/7004 , A61K31/7016 , A61K35/741 , A61K35/00
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号：US20180147222A1
公开(公告)日：2018-05-31
申请号：US15624372
申请日：2017-06-15
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K31/716 , A23P10/00 , A61K45/06 , A61K35/741 , A61K31/733 , A23L33/10 , A61K31/7016 , A61K31/7004 , A61K35/00
CPC classification number: A61K31/702 , A23L33/10 , A23P10/00 , A23V2002/00 , A61K31/7004 , A61K31/7016 , A61K31/716 , A61K31/733 , A61K35/741 , A61K45/06 , A61K2035/115 , A61P1/00 , Y02A50/475 , Y02A50/481
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号：US20170246201A1
公开(公告)日：2017-08-31
申请号：US15286382
申请日：2016-10-05
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/716
CPC classification number: A61K31/716 , A61K31/09 , A61K31/11 , A61K31/12 , A61K31/165 , A61K31/34 , A61K31/353 , A61K31/365 , A61K31/366 , A61K31/7034 , A61K31/7048 , A61K31/706 , A61K31/715 , A61K2035/115
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
Patent Agency Ranking
公开(公告)号：US11229660B2
公开(公告)日：2022-01-25
申请号：US16883107
申请日：2020-05-26
Applicant: Kaleido Biosciences, Inc.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K45/06 , A61K31/716 , A61K31/733 , A61P1/00 , A61K31/09 , A61K31/11 , A61K31/12 , A61K31/165 , A61K31/34 , A61K31/353 , A61K31/365 , A61K31/366 , A61K31/7034 , A61K31/7048 , A61K31/706 , A61K31/715 , A23L33/10 , A23P10/00 , A61K31/7004 , A61K31/7016 , A61K35/741 , A61K35/00
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号：US20200093845A1
公开(公告)日：2020-03-26
申请号：US16396067
申请日：2019-04-26
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K35/741 , A61K31/7016 , A61K31/7004 , A23P10/00 , A23L33/10 , A61P1/00 , A61K31/733 , A61K31/716 , A61K45/06
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号：US20200009168A1
公开(公告)日：2020-01-09
申请号：US16270051
申请日：2019-02-07
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , John M. Geremia
IPC: A61K31/7004 , C12Q1/10 , A61K35/741 , A61K31/7016 , A61K31/047 , A61K9/00 , A61K31/198 , A61K31/197 , A61K31/19 , A61K45/06
Abstract: Compositions comprising microbiome regulators are provided, as well as methods of using the same for the modulation of the human microbiota and to treat or prevent related diseases, disorders, or conditions.
-
公开(公告)号：US09757403B2
公开(公告)日：2017-09-12
申请号：US15385331
申请日：2016-12-20
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/706 , A61K31/715 , A61K31/34 , A61K31/7034 , A61K31/365 , A61K31/12 , A61K31/7048 , A61K31/11 , A61K31/165 , A61K31/09 , A61K35/00 , A61K31/353 , A61K31/702 , A61K31/7004 , A61K31/7016 , A61K45/06 , A61K35/741
CPC classification number: A61K31/702 , A23L33/10 , A23P10/00 , A23V2002/00 , A61K31/7004 , A61K31/7016 , A61K31/716 , A61K31/733 , A61K35/741 , A61K45/06 , A61K2035/115 , A61P1/00 , Y02A50/475 , Y02A50/481
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号：US20170151268A1
公开(公告)日：2017-06-01
申请号：US15374511
申请日：2016-12-09
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor： Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K35/741 , A23P10/00 , A61K31/7016 , A23L33/10 , A61K45/06 , A61K31/7004
CPC classification number: A61K31/702 , A23L33/10 , A23P10/00 , A23V2002/00 , A61K31/7004 , A61K31/7016 , A61K31/716 , A61K31/733 , A61K35/741 , A61K45/06 , A61K2035/115 , A61P1/00 , Y02A50/475 , Y02A50/481
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
-
-
-
-
-
-
-
-
Search Results
35
records
(took 0.039 seconds)
